Human cancer cells require ATR for cell cycle progression following exposure to ionizing radiation

Paula Hurley, D. Wilsker, Fred Bunz

Research output: Contribution to journalArticle

Abstract

The vast majority of cancer cells have defective checkpoints that permit the cell cycle to progress in the presence of double-strand DNA breaks (DSBs) caused by ionizing radiation (IR) and radiomimetic drugs. ATR (ataxia telangiectasia-mutated and Rad3-related) has recently been shown to be activated by DSBs, although the consequences of this activity are largely unknown. In this report, we use advanced gene targeting methods to generate biallelic hypomorphic ATR mutations in human colorectal cancer cells and demonstrate that progression of the cancer cell cycle after IR treatment requires ATR. Cells with mutant ATR accumulated at a defined point at the beginning of the S phase after IR treatment and were unable to progress beyond that point, whereas cells at later stages of the S phase during the time of irradiation progressed and completed DNA replication. The prolonged arrest of ATR mutant cancer cells did not involve the ataxia telangiectasia mutated-dependent S-phase checkpoint, but rather closely resembled a previously characterized form of cell cycle arrest termed S-phase stasis. As ATR strongly contributed to clonogenic survival after IR treatment, these data suggest that blocking ATR activity might be a useful strategy for inducing S-phase stasis and promoting the radiosensitization of checkpoint-deficient cancer cells.

Original languageEnglish (US)
Pages (from-to)2535-2542
Number of pages8
JournalOncogene
Volume26
Issue number18
DOIs
StatePublished - Apr 19 2007

Fingerprint

Ataxia Telangiectasia
Ionizing Radiation
Cell Cycle
S Phase
Neoplasms
Double-Stranded DNA Breaks
Cell Cycle Checkpoints
S Phase Cell Cycle Checkpoints
Gene Targeting
DNA Replication
Colorectal Neoplasms
Mutation
Survival

Keywords

  • ATR
  • Cell cycle
  • Chk1
  • IR
  • S-phase stasis
  • Seckel

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Human cancer cells require ATR for cell cycle progression following exposure to ionizing radiation. / Hurley, Paula; Wilsker, D.; Bunz, Fred.

In: Oncogene, Vol. 26, No. 18, 19.04.2007, p. 2535-2542.

Research output: Contribution to journalArticle

@article{5a4f7b15b0414b35921f29cc66fde3cf,
title = "Human cancer cells require ATR for cell cycle progression following exposure to ionizing radiation",
abstract = "The vast majority of cancer cells have defective checkpoints that permit the cell cycle to progress in the presence of double-strand DNA breaks (DSBs) caused by ionizing radiation (IR) and radiomimetic drugs. ATR (ataxia telangiectasia-mutated and Rad3-related) has recently been shown to be activated by DSBs, although the consequences of this activity are largely unknown. In this report, we use advanced gene targeting methods to generate biallelic hypomorphic ATR mutations in human colorectal cancer cells and demonstrate that progression of the cancer cell cycle after IR treatment requires ATR. Cells with mutant ATR accumulated at a defined point at the beginning of the S phase after IR treatment and were unable to progress beyond that point, whereas cells at later stages of the S phase during the time of irradiation progressed and completed DNA replication. The prolonged arrest of ATR mutant cancer cells did not involve the ataxia telangiectasia mutated-dependent S-phase checkpoint, but rather closely resembled a previously characterized form of cell cycle arrest termed S-phase stasis. As ATR strongly contributed to clonogenic survival after IR treatment, these data suggest that blocking ATR activity might be a useful strategy for inducing S-phase stasis and promoting the radiosensitization of checkpoint-deficient cancer cells.",
keywords = "ATR, Cell cycle, Chk1, IR, S-phase stasis, Seckel",
author = "Paula Hurley and D. Wilsker and Fred Bunz",
year = "2007",
month = "4",
day = "19",
doi = "10.1038/sj.onc.1210049",
language = "English (US)",
volume = "26",
pages = "2535--2542",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "18",

}

TY - JOUR

T1 - Human cancer cells require ATR for cell cycle progression following exposure to ionizing radiation

AU - Hurley, Paula

AU - Wilsker, D.

AU - Bunz, Fred

PY - 2007/4/19

Y1 - 2007/4/19

N2 - The vast majority of cancer cells have defective checkpoints that permit the cell cycle to progress in the presence of double-strand DNA breaks (DSBs) caused by ionizing radiation (IR) and radiomimetic drugs. ATR (ataxia telangiectasia-mutated and Rad3-related) has recently been shown to be activated by DSBs, although the consequences of this activity are largely unknown. In this report, we use advanced gene targeting methods to generate biallelic hypomorphic ATR mutations in human colorectal cancer cells and demonstrate that progression of the cancer cell cycle after IR treatment requires ATR. Cells with mutant ATR accumulated at a defined point at the beginning of the S phase after IR treatment and were unable to progress beyond that point, whereas cells at later stages of the S phase during the time of irradiation progressed and completed DNA replication. The prolonged arrest of ATR mutant cancer cells did not involve the ataxia telangiectasia mutated-dependent S-phase checkpoint, but rather closely resembled a previously characterized form of cell cycle arrest termed S-phase stasis. As ATR strongly contributed to clonogenic survival after IR treatment, these data suggest that blocking ATR activity might be a useful strategy for inducing S-phase stasis and promoting the radiosensitization of checkpoint-deficient cancer cells.

AB - The vast majority of cancer cells have defective checkpoints that permit the cell cycle to progress in the presence of double-strand DNA breaks (DSBs) caused by ionizing radiation (IR) and radiomimetic drugs. ATR (ataxia telangiectasia-mutated and Rad3-related) has recently been shown to be activated by DSBs, although the consequences of this activity are largely unknown. In this report, we use advanced gene targeting methods to generate biallelic hypomorphic ATR mutations in human colorectal cancer cells and demonstrate that progression of the cancer cell cycle after IR treatment requires ATR. Cells with mutant ATR accumulated at a defined point at the beginning of the S phase after IR treatment and were unable to progress beyond that point, whereas cells at later stages of the S phase during the time of irradiation progressed and completed DNA replication. The prolonged arrest of ATR mutant cancer cells did not involve the ataxia telangiectasia mutated-dependent S-phase checkpoint, but rather closely resembled a previously characterized form of cell cycle arrest termed S-phase stasis. As ATR strongly contributed to clonogenic survival after IR treatment, these data suggest that blocking ATR activity might be a useful strategy for inducing S-phase stasis and promoting the radiosensitization of checkpoint-deficient cancer cells.

KW - ATR

KW - Cell cycle

KW - Chk1

KW - IR

KW - S-phase stasis

KW - Seckel

UR - http://www.scopus.com/inward/record.url?scp=34247332735&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247332735&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1210049

DO - 10.1038/sj.onc.1210049

M3 - Article

C2 - 17043640

AN - SCOPUS:34247332735

VL - 26

SP - 2535

EP - 2542

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 18

ER -